A carregar...

Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort Study

BACKGROUND: Evidence on PD-1/PD-L1-directed immune checkpoint inhibitor (ICI) therapy for advanced non-small-cell lung cancer (NSCLC) is mainly based on clinical trials in first- or second-line settings. OBJECTIVE: We aimed to investigate response and prognostic factors with special regard to third-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Target Oncol
Main Authors: Lang, David, Huemer, Florian, Rinnerthaler, Gabriel, Horner, Andreas, Wass, Romana, Brehm, Elmar, Akbari, Kaveh, Granitz, Marcel, Hutarew, Georg, Kaiser, Bernhard, Greil, Richard, Lamprecht, Bernd
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6875512/
https://ncbi.nlm.nih.gov/pubmed/31654203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-019-00679-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!